PRFX

PainReform Ltd.

0.49 USD
-0.05 (-9.28%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PainReform Ltd. stock is up 4.04% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 July’s closed higher than June. 100% of analysts rate it a buy.

About PainReform Ltd.

PainReform Ltd. engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair.